FIELD: medicine, oncology, pharmaceutics. SUBSTANCE: the innovation represents medicinal preparation efficient in cancer therapy and new medicinal preparation containing double-chain RNA as, for example, poly (I) • poly (C), concretely, and activator of cancer cell intracellular nuclease containing 2-O-(2- diethylaminoethyl)- carbamoil-1.3-O-dioleoilglycerol, and composition including a carrier obtained out of phospholipid as the main component, and poly (I) • poly (C) or poly (I) • poly (C) uncoupled along its foundations. EFFECT: higher efficiency of preparation in cancer therapy at its lower toxicity. 6 cl, 10 ex, 3 tbl, 2 fig
Title | Year | Author | Number |
---|---|---|---|
DRUG CARRIER | 2008 |
|
RU2476204C2 |
POLYNUCLEOTIDE WITH TRUNCATED CHAIN AND METHOD FOR ITS PREPARING | 2000 |
|
RU2238279C2 |
METHOD FOR PREPARING NUCLEIC ACID-CONTAINING COMPOSITE PREPARATION | 1999 |
|
RU2222334C2 |
GLYCEROL DERIVATIVES, AN AGENT FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2123492C1 |
PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACID COPOLYMER | 1994 |
|
RU2143903C1 |
INHALATION FATTY EMULSION | 1999 |
|
RU2212230C2 |
ACTIVATORS OF POTASSIUM CHANNELS | 1999 |
|
RU2204390C2 |
MEDICINAL AGENT FOR TREATMENT OF CHRONIC ARTICULAR RHEUMATISM | 2002 |
|
RU2282446C2 |
MEDICINAL COMPOSITION AND TRIAZINE DERIVATIVES | 1995 |
|
RU2147233C1 |
HETEROCYCLIC DERIVATIVE AND A DRUG | 1995 |
|
RU2128996C1 |
Authors
Dates
2002-06-20—Published
1998-10-15—Filed